Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 9/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.32 |
| ▸ | GRK6 | P43250 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3452805 | 0.98 | CNR2 (0.35) | CNR2KMT2ALMNASMN1; SMN2TP53 | |
| SCHEMBL4936634 | 0.84 | KMT2A (0.39) | CNR2KMT2ALMNASMN1; SMN2TP53 | |
| SCHEMBL13086215 | 0.81 | CNR2 (0.41) | CNR2KMT2AALDH1A1L3MBTL1MEN1 | |
| SCHEMBL4443205 | 0.81 | CYP2D6 (0.44) | CNR2KMT2ALMNATP53ALDH1A1 | |
| SCHEMBL9347243 | 0.80 | LTA4H (0.38) | CNR2KMT2ALMNASMN1; SMN2NPSR1 | |
| SCHEMBL25081942 | 0.77 | MAPK1 (0.41) | KMT2ASMN1; SMN2ALDH1A1L3MBTL1MEN1 | |
| SCHEMBL16749608 | 0.77 | CYP19A1 (0.43) | — | |
| SCHEMBL25082006 | 0.77 | MAPK1 (0.41) | KMT2ASMN1; SMN2ALDH1A1L3MBTL1MEN1 | |
| SCHEMBL4434764 | 0.76 | MAPT (0.45) | KMT2AATMALDH1A1L3MBTL1MEN1 | |
| SCHEMBL9644373 | 0.75 | ALDH1A1 (0.41) | CNR2KMT2ALMNASMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3461908-B1 | MEASUREMENT OF GLYCOPROTEIN | ARKRAY INC (JP) | 2023-08-30 | — | — | EP | claimed |
| US-11313863-B2 | Measurement of glycoprotein | ARKRAY, INC. (JP) | 2022-04-26 | — | — | US | claimed |
| US-11262365-B2 | Kit for hemoglobin A1C quantitative analysis | I-SENS, INC. (KR) | 2022-03-01 | — | — | US | claimed |
| EP-3527669-B1 | KIT FOR HEMOGLOBIN A1C QUANTITATIVE ANALYSIS | I SENS INC (KR) | 2020-04-29 | — | — | EP | claimed |
| EP-3527669-A1 | KIT FOR HEMOGLOBIN A1C QUANTITATIVE ANALYSIS | i-Sens, Inc. (KR) | 2019-08-21 | — | — | EP | claimed |
| US-20190242910-A1 | KIT FOR HEMOGLOBIN A1C QUANTITATIVE ANALYSIS | I-SENS, INC. (KR) | 2019-08-08 | — | — | US | claimed |
| US-20190137509-A1 | Measurement of Glycoprotein | ARKRAY, INC. (JP) | 2019-05-09 | — | — | US | claimed |
| EP-3461908-A1 | MEASUREMENT OF GLYCOPROTEIN | ARKRAY, Inc. (JP) | 2019-04-03 | — | — | EP | claimed |
| US-8557591-B2 | Methods for assaying percentage of glycated hemoglobin | GENERAL ATOMICS (US) | 2013-10-15 | — | — | US | claimed |
| EP-1515144-B2 | METHOD OF ASSAY WITH SULFONIC ACID COMPOUND AND NITRO COMPOUND | ARKRAY INC (JP) | 2013-04-24 | — | — | EP | claimed |
| EP-1515144-B1 | METHOD OF ASSAY WITH SULFONIC ACID COMPOUND AND NITRO COMPOUND | ARKRAY INC (JP) | 2009-10-14 | — | — | EP | claimed |
| EP-2044444-A1 | METHODS FOR ASSAYING PERCENTAGE OF GLYCATED HEMOGLOBIN | GENERAL ATOMICS (US) | 2009-04-08 | — | — | EP | claimed |
| US-20080299597-A1 | METHODS FOR ASSAYING PERCENTAGE OF GLYCATED HEMOGLOBIN | DIAZYME LABORATORIES, INC. | 2008-12-04 | — | — | US | claimed |
| US-20080096230-A1 | Methods for assaying percentage of glycated hemoglobin | DIAZYME LABORATORIES, INC. | 2008-04-24 | — | — | US | claimed |
| US-7354732-B2 | Method of assay with sulfonic acid compound and nitro compound | ARKRAY, INC. (JP) | 2008-04-08 | — | — | US | claimed |
| WO-2008013874-A1 | METHODS FOR ASSAYING PERCENTAGE OF GLYCATED HEMOGLOBIN | GENERAL ATOMICS (US) | 2008-01-31 | — | — | WO | claimed |
| US-20070026523-A1 | Method for stabilizing leuco dye | DAIICHI PURE CHEMICALS CO., LTD. (JP) | 2007-02-01 | — | — | US | claimed |
| EP-1726955-A1 | METHOD OF STABILIZING OXIDIZABLE COLOR-ASSUMING REAGENT | DAIICHI PURE CHEMICALS CO., LTD. (JP) | 2006-11-29 | — | — | EP | claimed |
| US-20050221415-A1 | Method of assay with sulfonic acid compound and nitro compound | ARKRAY, INC. (JP) | 2005-10-06 | — | — | US | claimed |
| EP-1515144-A1 | METHOD OF ASSAY WITH SULFONIC ACID COMPOUND AND NITRO COMPOUND | ARKRAY, Inc. (JP) | 2005-03-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190137509-A1 | Measurement of Glycoprotein | CD4, SIGLEC7, FUT7 | CNR2 4122/4885KMT2A 4613/4885LMNA 1845/4885 |
| US-11313863-B2 | Measurement of glycoprotein | HBG1, HBG2, HBB | CNR2 1696/4885KMT2A 3253/4885LMNA 1137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.